819 related articles for article (PubMed ID: 24583059)
1. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.
Lähdeaho ML; Kaukinen K; Laurila K; Vuotikka P; Koivurova OP; Kärjä-Lahdensuu T; Marcantonio A; Adelman DC; Mäki M
Gastroenterology; 2014 Jun; 146(7):1649-58. PubMed ID: 24583059
[TBL] [Abstract][Full Text] [Related]
2. No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.
Murray JA; Kelly CP; Green PHR; Marcantonio A; Wu TT; Mäki M; Adelman DC;
Gastroenterology; 2017 Mar; 152(4):787-798.e2. PubMed ID: 27864127
[TBL] [Abstract][Full Text] [Related]
3. A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
Schuppan D; Mäki M; Lundin KEA; Isola J; Friesing-Sosnik T; Taavela J; Popp A; Koskenpato J; Langhorst J; Hovde Ø; Lähdeaho ML; Fusco S; Schumann M; Török HP; Kupcinskas J; Zopf Y; Lohse AW; Scheinin M; Kull K; Biedermann L; Byrnes V; Stallmach A; Jahnsen J; Zeitz J; Mohrbacher R; Greinwald R;
N Engl J Med; 2021 Jul; 385(1):35-45. PubMed ID: 34192430
[TBL] [Abstract][Full Text] [Related]
4. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease.
Kurppa K; Paavola A; Collin P; Sievänen H; Laurila K; Huhtala H; Saavalainen P; Mäki M; Kaukinen K
Gastroenterology; 2014 Sep; 147(3):610-617.e1. PubMed ID: 24837306
[TBL] [Abstract][Full Text] [Related]
5. Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.
Tack GJ; van de Water JM; Bruins MJ; Kooy-Winkelaar EM; van Bergen J; Bonnet P; Vreugdenhil AC; Korponay-Szabo I; Edens L; von Blomberg BM; Schreurs MW; Mulder CJ; Koning F
World J Gastroenterol; 2013 Sep; 19(35):5837-47. PubMed ID: 24124328
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study.
Lähdeaho ML; Scheinin M; Vuotikka P; Taavela J; Popp A; Laukkarinen J; Koffert J; Koivurova OP; Pesu M; Kivelä L; Lovró Z; Keisala J; Isola J; Parnes JR; Leon F; Mäki M
Lancet Gastroenterol Hepatol; 2019 Dec; 4(12):948-959. PubMed ID: 31494096
[TBL] [Abstract][Full Text] [Related]
7. Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease.
Tuire I; Marja-Leena L; Teea S; Katri H; Jukka P; Päivi S; Heini H; Markku M; Pekka C; Katri K
Am J Gastroenterol; 2012 Oct; 107(10):1563-9. PubMed ID: 22825364
[TBL] [Abstract][Full Text] [Related]
8. The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo.
Tye-Din JA; Anderson RP; Ffrench RA; Brown GJ; Hodsman P; Siegel M; Botwick W; Shreeniwas R
Clin Immunol; 2010 Mar; 134(3):289-95. PubMed ID: 19942485
[TBL] [Abstract][Full Text] [Related]
9. Emerging drugs for celiac disease.
Freeman HJ
Expert Opin Emerg Drugs; 2015 Mar; 20(1):129-35. PubMed ID: 25494908
[TBL] [Abstract][Full Text] [Related]
10. Gluten sensitivity in the rectal mucosa of first-degree relatives of celiac disease patients.
Dezi R; Niveloni S; Sugai E; Pedreira S; Smecuol E; Vazquez H; Doldan I; Cabanne A; Boerr L; Valero J; Kogan Z; Mauriño E; Bai JC
Am J Gastroenterol; 1997 Aug; 92(8):1326-30. PubMed ID: 9260799
[TBL] [Abstract][Full Text] [Related]
11. Gliadin does not induce mucosal inflammation or basophil activation in patients with nonceliac gluten sensitivity.
Bucci C; Zingone F; Russo I; Morra I; Tortora R; Pogna N; Scalia G; Iovino P; Ciacci C
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1294-1299.e1. PubMed ID: 23639603
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Transcriptomic Analysis of Intestinal Mucosa in Celiac Disease Patients on a Gluten-Free Diet and Postgluten Challenge.
Dotsenko V; Oittinen M; Taavela J; Popp A; Peräaho M; Staff S; Sarin J; Leon F; Isola J; Mäki M; Viiri K
Cell Mol Gastroenterol Hepatol; 2021; 11(1):13-32. PubMed ID: 32745639
[TBL] [Abstract][Full Text] [Related]
13. Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease.
Taavela J; Kurppa K; Collin P; Lähdeaho ML; Salmi T; Saavalainen P; Haimila K; Huhtala H; Laurila K; Sievänen H; Mäki M; Kaukinen K
Clin Gastroenterol Hepatol; 2013 Feb; 11(2):166-71.e1. PubMed ID: 23063678
[TBL] [Abstract][Full Text] [Related]
14. Histological, immunohistochemical and mRNA gene expression responses in coeliac disease patients challenged with gluten using PAXgene fixed paraffin-embedded duodenal biopsies.
Taavela J; Viiri K; Popp A; Oittinen M; Dotsenko V; Peräaho M; Staff S; Sarin J; Leon F; Mäki M; Isola J
BMC Gastroenterol; 2019 Nov; 19(1):189. PubMed ID: 31730447
[TBL] [Abstract][Full Text] [Related]
15. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial.
Biesiekierski JR; Newnham ED; Irving PM; Barrett JS; Haines M; Doecke JD; Shepherd SJ; Muir JG; Gibson PR
Am J Gastroenterol; 2011 Mar; 106(3):508-14; quiz 515. PubMed ID: 21224837
[TBL] [Abstract][Full Text] [Related]
16. Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge.
Murray JA; Syage JA; Wu TT; Dickason MA; Ramos AG; Van Dyke C; Horwath I; Lavin PT; Mäki M; Hujoel I; Papadakis KA; Bledsoe AC; Khosla C; Sealey-Voyksner JA;
Gastroenterology; 2022 Dec; 163(6):1510-1521.e6. PubMed ID: 35931103
[TBL] [Abstract][Full Text] [Related]
17. Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity.
Brottveit M; Beitnes AC; Tollefsen S; Bratlie JE; Jahnsen FL; Johansen FE; Sollid LM; Lundin KE
Am J Gastroenterol; 2013 May; 108(5):842-50. PubMed ID: 23588237
[TBL] [Abstract][Full Text] [Related]
18. Management of celiac disease: beyond the gluten-free diet.
Crowe SE
Gastroenterology; 2014 Jun; 146(7):1594-6. PubMed ID: 24786557
[No Abstract] [Full Text] [Related]
19. Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials.
Siegel M; Garber ME; Spencer AG; Botwick W; Kumar P; Williams RN; Kozuka K; Shreeniwas R; Pratha V; Adelman DC
Dig Dis Sci; 2012 Feb; 57(2):440-50. PubMed ID: 21948339
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
